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Abstract
Objectives: Because most research on long-term acute care hospitals has focused on Medicare, the objective of this
research is to describe the Georgia Medicaid population who received care at a long-term acute care hospital, the type and
volume of services provided by these long-term acute care hospitals, and the costs and outcomes of these services. For those
with select respiratory conditions, we descriptively compare costs and outcomes to those of patients who received care for
the same services in acute care hospitals.
Methods: We describe Georgia Medicaid recipients admitted to a long-term acute care hospital between 2011 and 2012.
We compare them to a population of Georgia Medicaid recipients admitted to an acute care hospital for one of five
respiratory diagnosis-related groups. Measurements used include patient descriptive information, admissions, diagnosisrelated groups, length of stay, place of discharge, 90-day episode costs, readmissions, and patient risk scores.
Results: We found that long-term acute care hospital admissions for Medicaid patients were fairly low (470 90-day episodes)
and restricted to complex cases. We also found that the majority of long-term acute care hospital patients were blind or
disabled (71.2%). Compared to patients who stayed at an acute care hospital, long-term acute care hospital patients had
higher average risk scores (13.1 versus 9.0), lengths of stay (61 versus 38 days), costs (US$143,898 versus US$115,056), but
fewer discharges to the community (28.4% versus 51.8%).
Conclusion: We found that the Medicaid population seeking care at long-term acute care hospitals is markedly different
than the Medicare populations described in other long-term acute care hospital studies. In addition, our study revealed
that Medicaid patients receiving select respiratory care at a long-term acute care hospital were distinct from Medicaid
patients receiving similar care at an acute care hospital. Our findings suggest that state Medicaid programs should carefully
consider reimbursement policies for long-term acute care hospitals, including bundled payments that cover both the original
hospitalization and long-term acute care hospital admission.
Keywords
Long-term acute care hospital, Medicaid, epidemiology/public health, respiratory medicine
Date received: 15 September 2015; accepted: 28 August 2016

Long-term acute care hospitals (LTACs) are acute care facilities that provide care for chronically critically ill patients for
an extended period of time, typically greater than 25 days.1
LTACs may best be known for intense respiratory care where
patients are mechanically ventilated and, ideally, weaned
from such care. The needs of LTAC patients are complex;
hence, LTACs are an expensive setting of care. Medicare
spent US$39,000 per LTAC visit in 2011,1 compared to
1997, when the median case cost was US$28,499.2 Because
Medicaid coverage of LTACs is optional for states, coverage
and reimbursement of LTAC services differ between
Medicaid programs and merits further research. Georgia
Medicaid does not distinguish between LTACs and other
hospitals. Therefore, participating LTACs are reimbursed

through the same diagnosis-related group (DRG) methodology used for all Georgia hospitals; there are no separate rules
or requirements for LTAC coverage.3
The majority of research on LTACs has drawn from samples of Medicare patients, with very few studies that include
a Medicaid population. Findings on the costs and outcomes
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experienced by Medicare patients who received care at an
LTAC are mixed. Kahn and Carson4 found that a transfer to
an LTAC was associated with lower post-acute care (PAC)
(US$9463 lower) and total (US$13,442 lower) costs, but
higher overall Medicare payments (US$15,592 higher). A
study commissioned by the Centers for Medicare and
Medicaid Services (CMS) found that patients referred to
LTACs had higher costs and higher payments compared to
similar patients who were not transferred to LTACs, but that
the magnitude of the difference varied by the patient’s primary diagnosis.5 Despite the additional costs, studies have
yet to conclusively show that LTAC-level care leads to desirable outcomes, including shortened lengths of stay, lower
mortality, or fewer readmissions.1,6–10

New contribution
The nearly exclusive focus of the current LTAC research on
the Medicare population and program has resulted in a dearth
of studies on LTAC services for the Medicaid population. To
our knowledge, only two studies have focused on LTAC care
for Medicaid beneficiaries. A report on California Medicaid’s
program found that in 2008, 4463 dual-eligible Californians
received care at an LTAC at an average cost of US$51,446
per patient (all Medicare spending).11 In another descriptive
analysis, Liu et al.2 reported that in 1997, 9.4% of all LTAC
discharges nationally were for Medicaid beneficiaries. The
authors also noted that the median length of stay for Medicaid
patients was 40.2 days, compared to 30.4 days for Medicare
beneficiaries.
This gap in the literature is important because outcomes,
costs, and utilization of Medicare beneficiaries at LTACs
may not be representative of the Medicaid population. With
very little research on Medicaid beneficiaries and LTACs,
state policy makers are left with evidence that is potentially
not representative of the population for which they are making coverage decisions. Furthermore, given that patients who
receive care at LTACs are some of the most high-cost/highneed beneficiaries, policy makers should place an emphasis
on this population if they hope to lower costs for their
Medicaid program. Knowing which Medicaid populations
receive care from LTACs and their associated outcomes
could inform coverage decisions, payment models, prior
authorization criteria, and coordination of care initiatives for
state Medicaid programs. In addition, if many Medicaid
LTAC patients are also eligible for Medicare, this research
could inform federal–state joint policies intended to improve
care for this vulnerable population.

Research objective
The objective of this research is to describe the Georgia
Medicaid population who received care at an LTAC, the type
and volume of services provided by these LTACs, and the
costs and outcomes associated with these services. For those

with select respiratory conditions, we also compare costs and
outcomes to those of patients who received care for the same
services in acute care hospitals (ACHs).
Our research builds on the premise that patients with
select respiratory conditions may experience improved outcomes when receiving specialized care as compared to similar patients who receive non-specialized care. As mentioned
previously, LTACs are unique in that they provide intense
respiratory care for patients who require prolonged mechanical ventilation.12 LTACs, as opposed to intensive care units
(ICUs), may offer specialized multidisciplinary teams,
advanced weaning protocols, and experience with a niche
group of patients with similar and complex needs.4 ICUs, on
the other hand, may be more likely to stabilize the patient but
serve a far greater variety of patient needs, thereby limiting
their ability to specialize their care on one group.4
Our comparative analysis focuses on a subset of the
Medicaid population with select respiratory conditions. We
seek to understand both the differences in the demographic
and cost characteristics of those who are admitted to an
LTAC as compared to those who receive care in alternative
settings. Our work adds to that of previous studies, focused
on Medicare patients, by assessing the value of LTACs for a
different group of complex patients.

Methods
Data sources and study sample
We used Georgia Medicaid claims data from January 2011
through December 2012. Our study sample consisted of feefor-service Medicaid members who were admitted to an
LTAC. As of 1 July 2011, 39% of Georgia Medicaid members were enrolled in fee-for-service Medicaid.13
Study design and measures. We performed a descriptive analysis to better understand the demographic characteristics,
primary diagnoses, and total Medicaid costs for Medicaid
patients who were served by LTACs. We constructed 90-day
episodes of care based on an ACH visit that immediately led
to an LTAC stay. (Start dates for the 90-day episode began at
the LTAC visit for patients who were not transferred from an
ACH.) This is a common approach in the literature as this
patient population has complex needs and is commonly
served by multiple facilities.5,14 We then performed an outcomes’ analysis of Medicaid members with one or more
LTAC visits, including length of stay, place of discharge,
30-day hospital readmissions, and per-patient costs for
patients admitted by each LTAC covered by the Georgia
Medicaid program. (We excluded episodes where the patient
was discharged to multiple LTACs within the same episode
and all episodes that began on 30 September 2012 or later.)
We determined the average length of stay at the originating
ACH and the patient’s time at the LTAC. The place of discharge variable included five potential settings: (1) ACH; (2)
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PAC facility, which includes skilled nursing and inpatient
rehabilitation facilities; (3) community, where the patient
was discharged home or to a home health service; (4) death;
and (5) all other. We defined 30-day readmissions as an
admission to an ACH within 30 days of being discharged to
the community. Readmissions that occurred beyond the
90-day episode window but were within 30 days of discharge
were included. We limited our cost measures to patients who
survived the 90-day episode and excluded dual-eligibles.
Our data included only Medicaid costs; thus, cost estimates
for dual-eligibles would have been inaccurate as the amount
paid by Medicare was unobserved. Costs captured all Medicaid reimbursed medical payments for services beginning
within the 90-day episode.
Finally, we conducted a comparative analysis to measure differences in outcomes and costs for patients with
similar conditions who received care at an LTAC, compared with patients who remained at an ACH. We again
analyzed the length of stay, place of discharge, 30-day hospital readmissions, and per-patient costs for patients in both
these settings and tested for statistical significance between
both groups for each variable. We focused on episodes that
originated at the ACH and had no previous LTAC or skilled
nursing facility admissions during the 2-year time frame.
ACHs were selected if the facility was located within or
bordering the counties in which any of the LTACs are
located. In order to create similar samples between the
ACH and the LTAC, we retained only admissions with at
least a 14-day length of stay and limited our comparative
analysis sample to admissions for one of five respiratoryrelated DRGs. These five DRGs constituted approximately
45% of all Georgia Medicaid LTAC admissions and
included the following: (All DRG codes are from the
Tricare version 30 DRG grouper.)

each patient.15–17 We report average CDPS + Rx risk scores
for each setting of care. As a sensitivity analysis, we restricted
the range of conditions to conduct a sub-analysis using only
one DRG (565—respiratory system diagnosis with ventilator
support for more than 96 h).
This research was reviewed and approved by the Georgia
State University Institutional Review Board.

•• DRG 542—tracheostomy with mechanical ventilation for more than 96 h or principal diagnosis except
face, mouth, and neck
•• DRG 565—respiratory system diagnosis with ventilator support for more than 96 h
•• DRG 87—pulmonary edema and respiratory failure
•• DRG 541—extracorporeal membrane oxygenation or
tracheostomy with mechanical ventilation for more
than 96 h or principal diagnosis except face, mouth,
and neck with major operating room procedure
•• DRG 566—respiratory system diagnosis with ventilator support for less than 96 h

The five LTACs admitted 458 patients for 470 episodes,
ranging from 46 to 258 episodes at each LTAC. Overall,
37.2% of the patients were discharged to another PAC, and
34.3% were discharged to the community. Just over 10%
were discharged back to an ACH, 12.3% died, and 5.5% had
other discharge statuses. Of the 161 patients who were discharged to the community, 38 (23.6%) were readmitted to an
ACH within 30 days. There were 47 readmissions among
these 38 patients, indicating multiple readmissions for certain patients.
The average length of stay at an ACH prior to discharge to
an LTAC was 20 days. Once at the LTAC, Medicaid patients
stayed for 36 days on average. Among the five LTACs, the
average length of stay ranged from 29 to 40 days.
The average overall cost of a 90-day episode for a nondual not deceased Medicaid member, including ACH, LTAC,
and other costs, was US$119,795. This figure includes average ACH costs of US$69,676, LTAC costs of US$46,805,
and all other costs (including any outpatient services at any
provider) of US$3313.

To examine differences in severity of illness between
ACH and LTAC patients, we calculated the Chronic Illness
and Disability Payment System + Rx (CDPS + Rx) score
using 2011 and 2012 claims data. The CDPS + Rx incorporates demographic information, 15,000 International
Classification of Diseases (ICD)-9 codes, and pharmacy data
into diagnostic buckets in order to generate a risk score for

Results
Descriptive analysis
We identified six LTACs that provided services to Medicaid
members between 2011 and 2012. One LTAC specialized in
neurological and spine care. Given that the diagnoses served
by this LTAC were substantially different than the other five
LTACs, and that respiratory care is more common nationally
at LTACs,18 we excluded this facility from the remainder of
the analysis. The remaining five LTACs provided inpatient
services for 458 Medicaid patients during the study period
(see Table 1). Seventy-one percent of these patients were eligible for Medicaid due to blindness or disability. While
approximately 52% of patients receiving LTAC inpatient
services were dually eligible for both Medicaid and Medicare,
the average age of patients receiving LTAC services was
56 years old. We calculated the total 2-year Medicaid expenditures for non-dual members who received care from an
LTAC as a benchmark for their total Medicaid costs. The
median total Medicaid cost for these members was
US$149,312. The range of expenditures was wide, from
US$86,811 in the 25th percentile to US$242,927 in the 75th
percentile.

Outcomes analysis
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Table 1. Descriptive characteristics, outcomes, and costs of
patients who received LTAC inpatient services.
Descriptive characteristics
Number of patients
Number of 90-day episodes
Eligibility type, n (%)
Aged
Blind and disabled
Medically needy
Other
Dual status, n (%)
Dual
Non-dual
Age (years)
Average (SD)
Age 0–64, n (%)
Age >64, n (%)
Gender, n (%)
Male
Female
Outcomes
Discharge status, n (%)
ACH
PAC
Community
Died
All other
Readmissionsa
Average length of stay (days)
Original ACH (SD)b
LTAC (SD)
Total (SD)
Costsc
Number of patients
Number of episodes
Avg. total cost per episode (US$)
Hospital care (SD)
LTAC care (SD)
Other (SD)
Total (SD)

   458
   470
60 (13.1)
326 (71.2)
12 (2.6)
60 (13.1)
239 (52.2)
219 (47.8)
56.5 (15.1)
333 (72.7)
125 (27.3)
202 (44.1)
256 (55.9)

50 (10.4)
175 (37.2)
161 (34.3)
58 (12.3)
26 (5.5)
38 (23.6)
20 (15.4)
36 (22.2)
56 (28.0)
187
194
69,676 (59,262)
46,805 (31,110)
3313 (4119)
119,795 (64,852)

SD: standard deviation; ACH: acute care hospital; PAC: post-acute care;
LTAC: long-term acute care hospital.
aReadmissions were calculated only for patients who were discharged to
the community.
bOriginal ACH only includes patient who were transferred to an LTAC
from an ACH.
cNumber of episodes are for non-dual and non-deceased patients.

Comparative analysis
The LTACs treated 211 respiratory-related episodes for 208
patients in 2011 and 2012 (see Table 2) compared to 821
episodes for 808 patients at ACHs. Patients who were treated
at an LTAC were older and more likely to be eligible for
Medicaid through a disability and had higher risk scores on
average than patients who remained in the ACH. The average risk score among the patients treated at an LTAC was

13.1, compared to 9.0 for patients who stayed at the ACH
(p < 0.01). While the distribution of the five DRGs was different between the ACH and LTAC groups, the risk scores
within each DRG were significantly higher for those that
received care at an LTAC.
Among the comparison group, 51.8% of episodes at
ACHs resulted in a discharge to the community, compared to
28.4% of LTAC admissions (p < 0.01; see Table 2). LTACs
discharged patients more frequently to another PAC (37.4%
versus 13.9%; p < 0.01), while a greater proportion of ACH
patients died before being discharged (18.2% versus 15.6%;
p < 0.01). Of the 425 patients discharged to the community
from ACHs, 87 (20.5%) were readmitted within 30 days of
discharge. However, because there were 105 total readmissions, it is clear that some patients experienced multiple
readmissions. LTACs discharged 60 patients (28.4%) to the
community, 14 (23.3%) of whom were readmitted within
30 days of discharge for 18 total readmissions. Differences in
readmissions rates between ACHs and LTACs were not statistically significant.
Non-deceased patients who received all their care at the
ACH had an average length of stay of 38 days, compared to
non-deceased patients admitted to an LTAC who had an
average length of stay of 19 days at the ACH followed by
42 days at the LTAC (see Table 3). The length of stay at the
ACH varied by discharge location. For example, those individuals discharged to the community from the ACH or LTAC
had an average length of stay of 37 and 56 days, respectively,
compared to those discharged to a PAC (42 and 64 days).
Among non-dual not deceased patients, the average total
cost of a 90-day episode at an LTAC was US$143,898, compared to US$115,056 for patients who remained at the ACH.
Costs related to the original hospitalization and post-discharge from the LTAC were lower on average for LTAC
patients compared to those that remained at the ACH.
The results of the sensitivity analysis using only DRG
565 were consistent with the comparative analysis presented
above (data not shown). Among 73 LTAC and 202 ACH episodes, a greater proportion of patients at ACHs were discharged to the community (59.7% versus 32.9%). The
average combined inpatient length of stay was 59 days at
LTACs versus 25 days at ACHs. Readmission rates were
higher among LTAC patients (20.8%) than ACHs (13.0%),
although sample sizes were small (24 and 123 patients were
discharged to the community, respectively). Finally, average
90-day costs among non-dual not deceased patients were
higher at LTACs (US$169,467) than at ACHs (US$76,304).

Discussion
Due to a lack of studies in the literature, little is known about
the population of Medicaid patients who receive care at LTACs.
Even less is known about the costs or outcomes of their care.
Our study contributes to the literature on LTAC patients by
describing the Medicaid population in Georgia who receive
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Table 2. Comparison of risk scores, discharge status, and readmissions for patients who received ACH only versus ACH and LTAC
inpatient services for select respiratory conditions.
Facility type

Descriptive characteristics
Number of patients
Eligibility type, n (%)
Aged
Blind and disabled
Medically needy
Other
Dual status, n (%)
Dual
Non-dual
Age (years)
Average (SD)
Age 0–64, n (%)
Age >64, n (%)
Gender, n (%)
Male
Female
Average risk score (SD)a
Outcomes
Number of 90-day episodes

ACH only

ACH and LTAC

808

208

46 (6)
589 (73)
88 (11)
84 (10)

17 (8)**
177 (85)**
Suppressed
Suppressed

218 (27)
589 (73)

61 (29)
147 (71)

45 (20.4)
709 (88)
98 (12)

56 (14.0)**
170 (82)**
38 (18)**

402 (50)
405 (50)
9.0 (3.6)

94 (45)
114 (55)
13.1 (3.4)**

821

211

Episodes by diagnosis-related group

n (%)

Average risk score (SD)

n (%)

Average risk score (SD)

DRG 542
DRG 565
DRG 87
DRG 541
DRG 566
Discharge status, n (%)
ACH
PAC
Community
Died
All other
Readmissionsb

214 (26)
203 (25)
55 (7)
271 (33)
78 (10)

9.04 (3.52)
9.10 (3.68)
9.34 (3.11)
9.27 (3.80)
8.36 (3.57)

79 (37)**
71 (34)**
30 (14)**
19 (9)**
12 (6)**

13.29 (3.81)**
12.66 (2.87)**
13.33 (3.45)**
14.16 (3.39)**
12.05 (3.74)**

15 (1.8)
114 (13.9)
425 (51.8)
149 (18.2)
118 (14.4)
87 (20.5)

26 (12.3)**
79 (37.4)**
60 (28.4)**
33 (15.6)**
13 (6.2)**
14 (23.3)

ACH: acute care hospital; LTAC: long-term acute care hospital; SD: standard deviation; CDPS + Rx: Chronic Illness and Disability Payment System + Rx.
Tests of statistical significance for discharge status and readmissions are chi-squared tests. A two-tailed t-test was used for differences in average risk
scores. Certain figures are suppressed to protect patient confidentiality because of low observation numbers.
DRG 542—tracheostomy with mechanical ventilation for more than 96 h or principal diagnosis except face, mouth, and neck.
DRG 565—respiratory system diagnosis with ventilator support for more than 96 h.
DRG 87—pulmonary edema and respiratory failure.
DRG 541—extracorporeal membrane oxygenation or tracheostomy with mechanical ventilation for more than 96 h or principal diagnosis except face,
mouth, and neck with major operating room procedure.
DRG 566—respiratory system diagnosis with ventilator support for less than 96 h.
aCDPS + Rx scores were calculated for 807 patients who remained at the ACH.
bReadmissions were calculated only for patients who were discharged to the community.
**p < 0.01.

care at LTACs. We also compared costs and outcomes for
Medicaid patients receiving select respiratory care in LTACs as
opposed to those receiving similar care in an ACH.
Our study revealed that the Medicaid population seeking
care at LTACs is markedly different than the Medicare

populations described in other LTAC studies, not just based
on patient age. Of the Medicaid patients who received care in
Georgia LTACs during the study period, we found that 71%
of them were blind or disabled. Our study also showed more
patients discharged to the community (34.3%) than prior
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Table 3. Comparison of length of stay and costs for patients
who received ACH only versus ACH and LTAC inpatient
services for select respiratory conditions, by discharge location.
Discharge
location
Overall
Average length of
stay (SD), days
At ACH
At LTAC
Total
Average cost
(SD), US$
ACH care
LTAC care
Other
Total
ACH
Average length of
stay (SD), days
At ACH
At LTAC
Total
Average cost
(SD), US$
ACH care
LTAC care
Other
Total
PAC
Average length of
stay (SD), days
At ACH
At LTAC
Total
Average cost
(SD),US$
ACH care
LTAC care
Other
Total
Community
Average length of
stay (SD), days
At ACH
At LTAC
Total
Average cost
(SD), US$
ACH care
LTAC care
Other
Total
Other
Average length of
stay (SD), days
At ACH

Table 3. (Continued)
Discharge
location

Facility type
ACH only

ACH and LTAC

At LTAC
Total
Average cost
(SD), US$
ACH care
LTAC care
Other
Total

–
37 (30.5)
N = 66

55 (24.1)
81 (37.8)**
N = suppressed

129,419 (166,808)
–
4654 (8371)
134,073 (165,479)

106,023 (56,349)
64,354 (30,710)
1465 (1700)**
171,842 (51,877)

Facility type
ACH only

ACH and LTAC

N = 672

N = 178

38 (28.6)
38 (28.6)
N = 481

19 (14.7)**
42 (24.4)
61 (28.2)**
N = 126

110,997 (110,438)
–
4059 (6794)
115,056 (109,802)

82,631 (53,184)**
58,384 (29,986)
2883 (3465)**
143,898 (50,934)**

N = 15

N = 26

–

28 (15.0)
28 (15.0)
N = suppressed

21 (22.5)
31 (24.0)
52 (32.0)**
N = suppressed

149,532 (101,175)
–
890 (885)
150,423 (101,225)

103,106 (58,902)
66,308 (33,242)
3046 (4667)*
172,460 (59,066)

N = 114

N = 79

–

42 (28.5)
42 (28.5)
N = 66

18 (11.1)**
47 (25.5)
64 (27.5)**
N = 51

137,737 (95,198)
–
2007 (3562)
139,744 (94,586)

80,066 (56,065)**
62,200 (30,918)
4096 (3947)**
146,362 (50,285)

N = 425

N = 60

–

37 (28.3)
37 (28.3)
N = 338

19 (11.2)**
38 (20.7)
56 (22.6)**
N = suppressed

100,925 (97,962)
–
4447 (6956)
105,372 (97,653)

74,485 (45,998)**
50,881 (26,952)
1848 (2114)**
127,214 (42,783)**

N = 118

N = 13

–

37 (30.5)

25 (25.8)

ACH: acute care hospital; LTAC: long-term acute care hospital; SD:
standard deviation; PAC: post-acute care.
Tests of statistical significance between overall ACH only and ACH and
LTAC are two-tailed t-tests. Length of stay totals may not sum correctly
due to rounding errors. Length of stays include non-deceased patients
only, and costs include non-deceased and non-dual patients only. Certain
figures are suppressed to protect patient confidentiality because of low
observation numbers.
*p < 0.1; **p < 0.01.

studies of Medicare patients (22%),6 as well as a much lower
mortality rate—12.3% as opposed to 48.2%−52.2% found
by Kahn et al.7 However, we found readmissions and costs to
be higher for Medicaid patients than those found in prior
studies of Medicare patients.2,7,9 In fact, the average episode
payments to an LTAC were approximately 20% higher for
this population than Medicare’s average payment in 2011
(US$46,805 versus US$39,000).1 Although many reasons
may exist for these differences, they demonstrate that prior
research using Medicare patients may not be appropriate for
informing state Medicaid policy for LTAC coverage.
In addition to differences with the Medicare population,
our study also revealed that Medicaid patients receiving
select respiratory care at an LTAC were distinct from
Medicaid patients receiving similar care at an ACH. We
found marked differences in terms of patient condition, discharge location, length of stay, and costs. In fact, our comparison of risk scores (both overall and within DRGs) shows
that these Medicaid patients are more seriously ill than those
who receive similar care at an ACH (13.1 for LTACs versus
9 for ACHs; p < 0.01). Therefore, it appears that LTACs are
treating a different and more complex set of Medicaid
patients.
The results of our study also imply that the Medicaid population receiving care at LTACs is more likely to experience
certain outcomes than their Medicare counterparts. This is
born out in the higher rate of discharge to the community for
this population (34.3%) as compared to Medicare patients
(22%). However, it is not clear why readmission rates are
higher for Medicaid patients. It may be that they are more
likely to be disabled than those on Medicare or that their
economic condition makes them less likely to seek appropriate and timely follow-up care with their primary care physician. Our comparative analysis with ACH patients does show
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LTAC Medicaid patients to have more serious conditions
than their ACH counterparts, but we did not have information on risk scores for Medicare patients to make similar
comparisons.
Our results have implications for providers and policy
makers. Although not required to do so, LTACs in Georgia
seemed to limit their Medicaid admissions to respiratory
cases of greater complexity than those observed in an ACH.
It is possible that physicians and hospitals are only referring
these difficult cases to LTACs, because they believe that
their patients are likely to receive better care, or that LTACs
are screening for these patients. In Georgia’s case, it may not
be necessary for the state Medicaid agency to impose admission restrictions on LTACs. In fact, Georgia places no more
admission restrictions on LTACs than they do for other acute
care facilities. Finally, much of the added expense of episodes that involve an LTAC transfer can be attributed to the
Medicaid program’s practice of paying two separate DRGs,
which may only save costs if the transfer is able to avoid an
outlier payment to an ACH. Therefore, Medicaid programs
may want to consider bundled payments for LTAC transfers.
A bundled payment would avoid paying two separate DRGs,
would cover transfers back to the original ACH—which happened frequently in our study population (10.4%)—and
would cover readmissions post-discharge to the community.
There are several limitations to this study. We only examined claims data for Georgia Medicaid patients enrolled in
fee-for-service Medicaid; thus, our results may not be generalizable to Medicaid patients in other states or in managed
care. More specific to our data, we excluded episodes where
a patient was discharged to multiple LTACs within the same
episode. Although this was likely a very small number of
patients, it removes a potentially informative population
from our analysis. In addition, costs were calculated only for
non-dual Medicaid patients, as we did not have access to
Medicare payment information, the primary payer for dualeligibles. Finally, our sample size for comparative analysis
was small, thereby limiting our ability to discuss associations between settings of care and patient outcomes.
Additional work including modeling that controls for the
impact of demographic and socioeconomic factors along
with patient severity is needed for more robust discussions
that assess the value of LTAC care on patient outcomes.
In spite of these limitations, our study found that Medicaid
patients who receive care at an LTAC are different from
Medicare patients, as well as Medicaid patients receiving
comparable care at an ACH. These findings may be informative to providers and policy makers when determining who is
best suited for LTAC care and what services Medicaid should
cover. However, further research is needed to determine
whether these differences between populations contribute
significantly to the differences in outcomes and costs that we
observed. Specifically, whether patient risk scores and other
demographic differences are predictive of outcomes and
costs for this population needs to be researched and analyzed. Further research should also focus on Medicaid

patients from multiple states in order to determine whether
our findings are generalizable to the broader Medicaid population and thus informative for providers and state Medicaid
policy makers in other states.
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